Research Output per year
Research Output per year
Fingerprint
Dive into the research topics where Gerardo Musuraca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 61 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
-
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML
Visani, G., Loscocco, F., Dennis, M., Zuffa, E., Candoni, A., Sensi, A., Giannini, B., Musuraca, G., Mianulli, A. M., Clavio, M., Rocchi, M., Gibellini, D., Navari, M., Gilkes, A., Piccaluga, P. P. & Isidori, A., Oct 19 2020, In : Blood advances. 4, 20, p. 5040-5049 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi
Merli, F., Cavallo, F., Salvi, F., Tucci, A., Musuraca, G., Nassi, L., Merli, M., Tani, M., Gini, G., Ferrari, A., Molinari, A. L., Liberati, A. M., Conconi, A., Matteucci, P., Bari, A., Scalone, R., Ferrero, S., Zanni, M., Mammi, C. & Luminari, S., 2020, In : Journal of Geriatric Oncology. 11, 1, p. 37-40 4 p.Research output: Contribution to journal › Article › peer-review
-
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)
Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, , Dec 2019, In : Leukemia and Lymphoma. 60, 12, p. 2890-2898 9 p.Research output: Contribution to journal › Article › peer-review
-
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)
Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, , Dec 1 2019, In : Leukemia and Lymphoma. 60, 12, p. 2890-2898 9 p.Research output: Contribution to journal › Article › peer-review
-
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)
Salvi, F., Luminari, S., Tucci, A., Massidda, S., Liberati, A. M., Stelitano, C., Zanni, M., Re, A., Centurioni, R., Freilone, R., Musuraca, G., Nassi, L., Patti, C., Arcari, A., Tani, M., Pulsoni, A., Pavone, V., Volpetti, S., Peli, A., Evangelista, A. & 3 others, , 2019, In : Leukemia and Lymphoma. 60, 12, p. 2890-2898 9 p.Research output: Contribution to journal › Article › peer-review